Show simple item record

dc.contributor.authorMahto, R.
dc.contributor.authorAhmed, S.U.
dc.contributor.authorRahman, R.
dc.contributor.authorAziz, R.M.
dc.contributor.authorRoy, P.
dc.contributor.authorMallik, S.
dc.contributor.authorLi, A.
dc.contributor.authorShah, M.A.
dc.date.accessioned2024-03-26T06:51:13Z
dc.date.available2024-03-26T06:51:13Z
dc.date.issued2023-12-15
dc.identifier.citationMahto, R., Ahmed, S.U., Rahman, R.u. et al. A novel and innovative cancer classification framework through a consecutive utilization of hybrid feature selection. BMC Bioinformatics 24, 479 (2023). https://doi.org/10.1186/s12859-023-05605-5
dc.identifier.issn1471-2105
dc.identifier.pmid38102551
dc.identifier.doi10.1186/s12859-023-05605-5
dc.identifier.urihttp://hdl.handle.net/10150/671843
dc.description.abstractCancer prediction in the early stage is a topic of major interest in medicine since it allows accurate and efficient actions for successful medical treatments of cancer. Mostly cancer datasets contain various gene expression levels as features with less samples, so firstly there is a need to eliminate similar features to permit faster convergence rate of classification algorithms. These features (genes) enable us to identify cancer disease, choose the best prescription to prevent cancer and discover deviations amid different techniques. To resolve this problem, we proposed a hybrid novel technique CSSMO-based gene selection for cancer classification. First, we made alteration of the fitness of spider monkey optimization (SMO) with cuckoo search algorithm (CSA) algorithm viz., CSSMO for feature selection, which helps to combine the benefit of both metaheuristic algorithms to discover a subset of genes which helps to predict a cancer disease in early stage. Further, to enhance the accuracy of the CSSMO algorithm, we choose a cleaning process, minimum redundancy maximum relevance (mRMR) to lessen the gene expression of cancer datasets. Next, these subsets of genes are classified using deep learning (DL) to identify different groups or classes related to a particular cancer disease. Eight different benchmark microarray gene expression datasets of cancer have been utilized to analyze the performance of the proposed approach with different evaluation matrix such as recall, precision, F1-score, and confusion matrix. The proposed gene selection method with DL achieves much better classification accuracy than other existing DL and machine learning classification models with all large gene expression dataset of cancer. © 2023, The Author(s).
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.rights© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectCancer classification
dc.subjectCuckoo search algorithm (CSA)
dc.subjectDeep learning (DL)
dc.subjectMinimum redundancy maximum relevance (mRMR)
dc.subjectSpider monkey optimization (SM)
dc.titleA novel and innovative cancer classification framework through a consecutive utilization of hybrid feature selection
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Pharmacology and Toxicology, University of Arizona
dc.identifier.journalBMC Bioinformatics
dc.description.noteOpen access journal
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal Published Version
dc.source.journaltitleBMC Bioinformatics
refterms.dateFOA2024-03-26T06:51:13Z


Files in this item

Thumbnail
Name:
s12859-023-05605-5.pdf
Size:
3.749Mb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.
Except where otherwise noted, this item's license is described as © The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.